Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tunodafil Hydrochloride and Alcohol Interaction Study
NCT05976503Phase 1Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Dec 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in erectile dysfunction (ED) comparing Tunodafil + Alcohol, Placebo + Alcohol and Tunodafil + Placebo Alcohol (3 arms). Primary endpoints: Maximum change in systolic blood pressure at 4 hours, Maximum change in diastolic blood pressure at 4 hours and 7 more. Started Dec 2022; status: completed.
02
Drugs
Tunodafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT05976503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05976503.